Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Activist vessel collides with krill trawler in Antarctic confrontation - 2Procter & Gamble changes Crest toothpaste packaging to address Texas AG fluoride concerns
- 3Woman charged in unprovoked stabbing of tourist changing baby's diaper in Macy’s Herald Square store
- 4Top 15 Web-based Entertainment Stages for Individual Marking
- 5Factbox-China's crewed lunar programme eyes astronaut landing by 2030
- NASA satellite gazes into Medusa Pool | Space photo of the day for Dec. 24, 2025
- Vote in favor of your #1 sort of juice
- Moscow: Russia well-positioned to withstand oil market shocks
- Instructions to Pick the Right Senior Protection Plan.
- Step by step instructions to Protect Your Speculations with Cd Rates
- 'The Housemaid' movie with Sydney Sweeney and Amanda Seyfried premieres this month. What the stars have said about the psychological thriller.
- Herzog, German Chancellor Merz discuss final Gaza hostage, Arrow 3 exchange in Jerusalem
- This Huge Ocean Beast Shifts Sharks’ Evolutionary Timeline
- Israel strikes Iranian nuclear development facilities, Tehran vows retaliation
